Antibiotic-Resistant Acinetobacter baumannii Increasing Success Remains a Challenge as a Nosocomial Pathogen

Antibiotic-Resistant Acinetobacter baumannii Increasing Success Remains a Challenge as a Nosocomial Pathogen

Item
http://www.wikidata.org/entity/Q26766333
Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance TrialAcinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: Molecular and drug susceptibility profiles.Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III.Constraint-based modeling identifies new putative targets to fight colistin-resistant A. baumannii infections.Pitfalls associated with evaluating enzymatic quorum quenching activity: the case of MomL and its effect on Pseudomonas aeruginosa and Acinetobacter baumannii biofilms.Phenotype microarray analysis of the AdeRS two-component system in Acinetobacter baumannii.A Nosocomial Outbreak of Extensively Drug Resistant (XDR) Acinetobacter baumannii Isolates Containing blaOXA-237 Encoded on a Plasmid.A1S_2811, a CheA/Y-like hybrid two-component regulator from Acinetobacter baumannii ATCC17978, is involved in surface motility and biofilm formation in this bacterium.Clinical Antibiotic-resistant Acinetobacter baumannii Strains with Higher Susceptibility to Environmental Phages than Antibiotic-sensitive Strains.In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii.LpxK Is Essential for Growth of Acinetobacter baumannii ATCC 19606: Relationship to Toxic Accumulation of Lipid A Pathway Intermediates.Chemical Composition and Pharmacological Effects of Geopropolis Produced by Melipona quadrifasciata anthidioides.Acinetobacter spp. Infections in Malaysia: A Review of Antimicrobial Resistance Trends, Mechanisms and Epidemiology.Substrate specificities and efflux efficiencies of RND efflux pumps of Acinetobacter baumannii.Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii.
P2860

Antibiotic-Resistant Acinetobacter baumannii Increasing Success Remains a Challenge as a Nosocomial Pathogen

Item
http://www.wikidata.org/entity/Q26766333
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Antibiotic-Resistant Acinetoba ...... lenge as a Nosocomial Pathogen
@ast
Antibiotic-Resistant Acinetoba ...... lenge as a Nosocomial Pathogen
@en
Antibiotic-Resistant Acinetoba ...... lenge as a Nosocomial Pathogen
@nl
type
label
Antibiotic-Resistant Acinetoba ...... lenge as a Nosocomial Pathogen
@ast
Antibiotic-Resistant Acinetoba ...... lenge as a Nosocomial Pathogen
@en
Antibiotic-Resistant Acinetoba ...... lenge as a Nosocomial Pathogen
@nl
prefLabel
Antibiotic-Resistant Acinetoba ...... lenge as a Nosocomial Pathogen
@ast
Antibiotic-Resistant Acinetoba ...... lenge as a Nosocomial Pathogen
@en
Antibiotic-Resistant Acinetoba ...... lenge as a Nosocomial Pathogen
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Antibiotic-Resistant Acinetoba ...... lenge as a Nosocomial Pathogen
@en
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P921
P932